大行評級|大和:予創科實業“買入”評級 相信其業務及基本面維持強勁
創科實業於昨日收市後公佈,Joseph Galli Jr.辭任執行董事兼行政總裁,並委任Steven Richman為新任行政總裁。大和發表研究報吿表示,相信創科新任行政總裁將能繼續推動公司取得成功,因為Steven Richman曾為創科實業旗下品牌美沃奇(Milwaukee)的關鍵管理層人員,而該品牌亦一直是創科2022至2024財年業績表現錄得增長的最強推動力。該行亦認為,上述管理層變動將不會對公司產生負面影響,並相信創科的業務及基本面將維持強勁。主要由於Pudwill家族仍擁有該業務約22%股份、現有高級管理人員非常穩定且能力強。該行將創科目標價定於108港元,並給予“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.